Resolution of Jaundice in a Patient With Primary Biliary Cholangitis on Obeticholic Acid

被引:0
|
作者
Barnhill, Michele [1 ]
Rangnekar, Amol [1 ]
机构
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2154
引用
收藏
页码:S1192 / S1192
页数:1
相关论文
共 50 条
  • [31] WAITLIST MORTALITY OF DECOMPENSATED PRIMARY BILIARY CHOLANGITIS PATIENTS IN THE OBETICHOLIC ACID ERA
    Sedki, Mai
    Kwong, Allison J.
    Mannalithara, Ajitha
    Goel, Aparna
    Kim, W. Ray
    HEPATOLOGY, 2021, 74 : 789A - 789A
  • [32] Hepatic Safety Overview of Obeticholic Acid for the Treatment of Patients with Primary Biliary Cholangitis
    Pockros, Paul J.
    Shiffman, Mitchell L.
    Bowlus, Christopher L.
    Sanyal, Arun J.
    Nevens, Frederik
    Pencek, Richard
    Shapiro, David A.
    Shah, Amrik
    MacConell, Leigh
    HEPATOLOGY, 2018, 68 : 1099A - 1099A
  • [33] Real World Experience With Obeticholic Acid for Primary Biliary Cholangitis: A Case Series
    Nellis, Eric
    Peyton, Adam
    Wong, She-Yan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1278 - S1278
  • [34] Reductions in Abnormal Direct Bilirubin with Obeticholic Acid in Patients with Primary Biliary Cholangitis
    Pares, Albert
    Vargas, Victor
    Shiffman, Mitchell L.
    Hirschfield, Gideon M.
    Invernizzi, Pietro
    Liberman, Alexander
    Malecha, Elizabeth Smoot
    Owens-Grillo, Janet
    Lopez-Talavera, Juan C.
    HEPATOLOGY, 2017, 66 : 174A - 174A
  • [35] DOSING CONSIDERATIONS FOR OBETICHOLIC ACID (OCA) IN THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC).
    Marathe, D.
    Yang, Y.
    Shang, E.
    Li, S.
    Zhao, P.
    Lee, S. -C.
    Mehta, R.
    Omokaro, S. O.
    Dimicksantos, L.
    Davis-Williams, A.
    Meyer, J.
    Egan, A.
    Roman, D.
    Bashaw, E. D.
    Sinha, V.
    Mehrotra, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S77 - S77
  • [36] EFFECTS OF OBETICHOLIC ACID ON APRI AND GLOBE SCORE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Harms, Maren H.
    Hirschfield, Gideon
    Floreani, Annarosa
    Mayo, Marlyn J.
    Pares, Albert
    Liberman, Alexander
    Malecha, Elizabeth Smoot
    Pencek, Richard
    MacConell, Leigh
    Hansen, Bettina E.
    HEPATOLOGY, 2019, 70 : 763A - 764A
  • [37] Bezafibrate improves the effect of obeticholic acid on cholestasis in patients with primary biliary cholangitis
    Smets, Lena
    Liliane, Schrijvers
    Hannelie, Korf
    Schalk, Van der Merwe
    Frederik, Nevens
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E130 - E130
  • [38] Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis
    John, Binu V.
    Schwartz, Kaley
    Levy, Cynthia
    Dahman, Bassam
    Deng, Yangyang
    Martin, Paul
    Taddei, Tamar H.
    Kaplan, David E.
    HEPATOLOGY COMMUNICATIONS, 2021, 5 (08) : 1426 - 1436
  • [39] Real-World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis
    Roberts, Surain B.
    Ismail, Marwa
    Kanagalingam, Gowthami
    Mason, Andrew L.
    Swain, Mark G.
    Vincent, Catherine
    Yoshida, Eric M.
    Tsien, Cynthia
    Flemming, Jennifer A.
    Janssen, Harry L. A.
    Hirschfield, Gideon M.
    Hansen, Bettina E.
    Gulamhusein, Aliya F.
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (09) : 1332 - 1345
  • [40] Obeticholic Acid in primary biliary Cholangitis PBC OCA International Study of Ffficacy (POISE)
    Gerken, G.
    Nitschmann, S.
    INTERNIST, 2017, 58 (02): : 202 - 204